Negative regulation of Th17 responses

Seminars in Immunology

Volumn 19, Issue 6, 2007, Pages 394-399

  Stumhofer, J S ^a   Silver, J ^a   Hunter, C A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Chronic inflammation; Cytokine; STAT; Th17

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 25; STAT PROTEIN;

CELL ACTIVITY; CELL LINEAGE; CELL MATURATION; CHRONIC INFLAMMATION; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; NONHUMAN; REVIEW; T LYMPHOCYTE; TH17 CELL;

ANIMALS; CYTOKINES; HUMANS; INTERLEUKIN-17; INTERLEUKIN-23; STAT TRANSCRIPTION FACTORS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 39549114268     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2007.11.006     Document Type: Review

References (68)

1. Mosmann T.T., Cherwinski H., Bond M.W., Giedlin M.A., and Coffman R.L. Two types of murine helper T cell clone I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136 (1986) 2348-2353
2. Murphy C.A., Langrish C.L., Chen Y., Blumenschein W., McClanahan T., Kastelein R.A., et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 198 (2003) 1951-1957
3. Chung Y., Yang X., Chang S.H., Ma L., Tian Q., and Dong C. Expression and regulation of IL-22 in the IL-17-producing CD4+T lymphocytes. Cell Res 16 (2006) 902-907
4. Liang S.C., Tan X.Y., Luxenberg D.P., Karim R., Dunussi-Joannopoulos K., Collins M., et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203 (2006) 2271-2279
5. Korn T., Bettelli E., Gao W., Awasthi A., Jager A., Strom T.B., et al. IL-21 initiates an alternative pathway to induce proinflammatory T (H)17 cells. Nature 448 (2007) 484-487
6. Nurieva R., Yang X.O., Martinez G., Zhang Y., Panopoulos A.D., Ma L., et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448 (2007) 480-483
7. Zhou L., Ivanov I.I., Spolski R., Min R., Shenderov K., Egawa T., et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 8 (2007) 967-974
8. Happel K.I., Dubin P.J., Zheng M., Ghilardi N., Lockhart C., Quinton L.J., et al. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J Exp Med 202 (2005) 761-769
9. Mangan P.R., Harrington L.E., O'Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., et al. Transforming growth factor-beta induces development of the T (H)17 lineage. Nature 441 (2006) 231-234
10. Cua D.J., Sherlock J., Chen Y., Murphy C.A., Joyce B., Seymour B., et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421 (2003) 744-748
11. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201 (2005) 233-240
12. Fujino S., Andoh A., Bamba S., Ogawa A., Hata K., Araki Y., et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52 (2003) 65-70
13. Zheng Y., Danilenko D.M., Valdez P., Kasman I., Eastham-Anderson J., Wu J., et al. Interleukin-22, a T (H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445 (2007) 648-651
14. Lubberts E., Koenders M.I., Oppers-Walgreen B., van den Bersselaar L., Coenen-de Roo C.J., Joosten L.A., et al. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 50 (2004) 650-659
15. O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8 (1998) 275-283
16. Murphy K.M., and Reiner S.L. The lineage decisions of helper T cells. Nat Rev Immunol 2 (2002) 933-944
17. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6 (2005) 1133-1141
18. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., et al. Interleukin 17-producing CD4 + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6 (2005) 1123-1132
19. Moore K.W., Viera P., Fiorentino D.F., Trounstine M.L., Khan T.A., and Mossman T.R. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 248 (1990) 1230-1233
20. Grunig G., Corry D.B., Leach M.W., Seymour B.W.P., Hurup vP., and Rennick D.M. Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J Exp Med 185 (1997) 1089-1099
21. Wynn T.A., Morawetz R., Scharton-Kersten T., Hieny S., Morse H.C., Kuhn R., et al. Analysis of granuloma formation in double cytokine-deficient mice reveals a central role for IL-10 in polarizing both T helper cell 1- and T helper cell 2-type cytokine responses in vivo. J Immunol 159 (1997) 5014-5023
22. Gazzinelli R.T., Wysocka M., Hieny S., Scharton-Kersten T., Cheever A., Kuhn R., et al. In the absence of endogenous IL-10 mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4 + T cells and accompanied by overproduction of IL-12, IFN-γ and TNF-α. J Immunol 157 (1996) 798-805
23. Hunter C.A., Ellis L., Slifer T., Kanaly S., Grunig G., Rennick D., et al. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J Immunol 158 (1997) 3311-3316
24. Ding L., and Shevach E.M. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. J Immunol 148 (1992) 3133-3139
25. de Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., and de Vries J.E. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174 (1991) 1209-1220
26. Ding L., Linsley P.S., Huang L.Y., Germain R.N., and Shevach E.M. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 151 (1993) 1224-1234
27. Kuhn R., Lohler J., Rennick D., Rajewsky K., and Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75 (1993) 263-274
28. + T cells, but not B cells, mediate colitis in interelukin 10-deficient mice. J Exp Med 184 (1996) 241-251
29. Berg D.J., Davidson N., Kuhn R., Muller W., Menon S., Holland G., et al. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4 + TH1-like responses. J Clin Investig 98 (1996) 1010-1020
30. Davidson N.J., Hudak S.A., Lesley R.E., Menon S., Leach M.W., and Rennick D.M. IL-12, but not IFN-γ, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice. J Immunol 161 (1998) 3143-3149
31. Oppmann B., Lesley R., Blom B., Timans J.C., Xu Y., Hunte B., et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13 (2000) 715-725
32. Aggarwal S., Ghilardi N., Xie M.H., de Sauvage F.J., and Gurney A.L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 278 (2003) 1910-1914
33. Yen D., Cheung J., Scheerens H., Poulet F., McClanahan T., and McKenzie B. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 116 (2006) 1310-1316
34. Kolls J.K., and Linden A. Interleukin-17 family members and inflammation. Immunity 21 (2004) 467-476
35. Owyang A.M., Zaph C., Wilson E.H., Guild K.J., McClanahan T., Miller H.R., et al. Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract. J Exp Med 203 (2006) 843-849
36. Fort M.M., Cheung J., Yen D., Li J., Zurawski S.M., Lo S., et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15 (2001) 985-995
37. Kleinschek M.A., Owyang A.M., Joyce-Shaikh B., Langrish C.L., Chen Y., Gorman D.M., et al. IL-25 regulates Th17 function in autoimmune inflammation. J Exp Med 204 (2007) 161-170
38. Seder R.A., Germain R.N., Linsley P.S., and Paul W.E. CD28-mediated costimulation of interleukin 2 production plays a critical role in T cell priming for IL-4 and interferon γ production. J Exp Med 179 (1994) 299-304
39. Sadlack B., Merz H., Schorle H., Schimpi A., Feller A.C., and Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75 (1993) 253-261
40. Laurence A., Tato C.M., Davidson T.S., Kanno Y., Chen Z., Yao Z., et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26 (2007) 371-381
41. Lohr J., Knoechel B., Wang J.J., Villarino A.V., and Abbas A.K. Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease. J Exp Med 203 (2006) 2785-2791
42. Chen Q., Ghilardi N., Wang H., Baker T., Xie M.H., Gurney A., et al. Development of Th1-type immune responses requires the type I cytokine receptor TCCR. Nature 407 (2000) 916-920
43. Yoshida H., Hamano S., Senaldi G., Covey T., Faggioni R., Mu S., et al. WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity 15 (2001) 569-578
44. Kastelein R.A., Hunter C.A., and Cua D.J. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu Rev Immunol 25 (2007) 221-242
45. Hunter C.A. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol 5 (2005) 521-531
46. Denkers E.Y., and Gazzinelli R.T. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin Microbiol Rev 11 (1998) 569-588
47. Villarino A., Hibbert L., Lieberman L., Wilson E., Mak T., Yoshida H., et al. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 19 (2003) 645-655
48. Hamano S., Himeno K., Miyazaki Y., Ishii K., Yamanaka A., Takeda A., et al. WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production. Immunity 19 (2003) 657-667
49. Rosas L.E., Satoskar A.A., Roth K.M., Keiser T.L., Barbi J., Hunter C., et al. Interleukin-27R (WSX-1/T-Cell Cytokine Receptor) gene-deficient mice display enhanced resistance to Leishmania donovani infection but develop severe liver immunopathology. Am J Pathol 168 (2006) 158-169
50. Holscher C., Holscher A., Ruckerl D., Yoshimoto T., Yoshida H., Mak T., et al. The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis. J Immunol 174 (2005) 3534-3544
51. Miyazaki Y., Inoue H., Matsumura M., Matsumoto K., Nakano T., Tsuda M., et al. Exacerbation of experimental allergic asthma by augmented Th2 responses in WSX-1-deficient mice. J Immunol 175 (2005) 2401-2407
52. Yamanaka A., Hamano S., Miyazaki Y., Ishii K., Takeda A., Mak T.W., et al. Hyperproduction of proinflammatory cytokines by WSX-1-deficient NKT cells in Concanavalin A-induced hepatitis. J Immunol 172 (2004) 3590-3596
53. Stumhofer J.S., Laurence A., Wilson E.H., Huang E., Tato C.M., Johnson L.M., et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol 7 (2006) 937-945
54. Batten M., Li J., Yi S., Kljavin N.M., Danilenko D.M., Lucas S., et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 7 (2006) 929-936
55. Fitzgerald D.C., Ciric B., Touil T., Harle H., Grammatikopolou J., Sarma J.D., et al. Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis. J Immunol 179 (2007) 3268-3275
56. Amadi-Obi A., Yu C.R., Liu X., Mahdi R.M., Clarke G.L., Nussenblatt R.B., et al. T (H)17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med 13 (2007) 711-718
57. Stumhofer J.S., Silver J.S., Laurence A., Porrett P.M., Harris T.H., Turka L.A., et al. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol 8 (2007) 1363-1371
58. Awasthi A., Carrier Y., Peron J.P., Bettelli E., Kamanaka M., Flavell R.A., et al. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat Immunol 8 (2007) 1380-1389
59. Fitzgerald D.C., Zhang G.X., El-Behi M., Fonseca-Kelly Z., Li H., Yu S., et al. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat Immunol 8 (2007) 1372-1379
60. McGeachy M.J., Bak-Jensen K.S., Chen Y., Tato C.M., Blumenschein W., McClanahan T., et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T (H)-17 cell-mediated pathology. Nat Immunol 8 (2007) 1390-1397
61. Anderson C.F., Oukka M., Kuchroo V.J., and Sacks D. CD4 + CD25-Foxp3-Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med 204 (2007) 285-297
62. Jankovic D., Kullberg M.C., Feng C.G., Goldszmid R.S., Collazo C.M., Wilson M., et al. Conventional T-bet + Foxp3-Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J Exp Med 204 (2007) 273-283
63. Molle C., Nguyen M., Flamand V., Renneson J., Trottein F., De Wit D., et al. IL-27 synthesis induced by TLR ligation critically depends on IFN regulatory factor 3. J Immunol 178 (2007) 7607-7615
64. Chen Z., Laurence A., Kanno Y., Pacher-Zavisin M., Zhu B.M., Tato C., et al. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc Natl Acad Sci U S A 103 (2006) 8137-8142
65. Mathur A.N., Chang H.C., Zisoulis D.G., Stritesky G.L., Yu Q., O'Malley J.T., et al. Stat3 and Stat4 direct development of IL-17-secreting Th cells. J Immunol 178 (2007) 4901-4907
66. Ivanov I.I., McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17 + T helper cells. Cell 126 (2006) 1121-1133
67. Kullberg M.C., Jankovic D., Feng C.G., Hue S., Gorelick P.L., McKenzie B.S., et al. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J Exp Med 203 (2006) 2485-2494
68. Hue S., Ahern P., Buonocore S., Kullberg M.C., Cua D.J., McKenzie B.S., et al. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med 203 (2006) 2473-2483